维多利亚州小细胞肺癌患者的护理模式,2011-19:一项回顾性,基于人口的注册数据研究
Joanna Huang1, Wasek Faisal2, Margaret Brand3
1Alfred Health, Melbourne, VIC.
The Medical journal of Australia
|June 26, 2023
概括
多学科会议,多模式治疗和早期化疗改善了小细胞肺癌 (SCLC) 患者的生存率. 改善支持性护理查和息性转诊对于更好的SCLC结果至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 癌症研究 癌症研究
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有独特治疗模式和生存率的侵袭性肺癌形式.
- 了解特定阶段的管理对于优化SCLC患者的治疗结果至关重要.
研究的目的:
- 分析小细胞肺癌 (SCLC) 的特定阶段治疗模式.
- 评估管理和治疗方式对SCLC存活率的影响.
- 确定与SCLC患者生存率改善相关的因素.
主要方法:
- 一项横截面研究分析了2011年至2019年期间从维多利亚肺癌登记处 (VLCR) 收集的前性数据.
- 包括维多利亚州所有新诊断的小细胞肺癌 (SCLC) 患者.
- 接受治疗的统计分析,人口统计数据,临床阶段,表现状况和生存结果.
主要成果:
- 诊断了1006名SCLC患者;70%的人被诊断为IV期.
- 89%的患者接受了积极治疗,化疗是最常见的 (84%).
- 在诊断后14天内进行多学科会议演讲,多模式治疗和化疗与显著降低死亡率有关.
结论:
- 有机会加强支持性护理查,多学科会议参与和SCLC患者的息护理转诊.
- 通过对管理和结果的标准化数据收集,建立国家SCLC注册表可以提高护理的质量和安全性.
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Standards of Care II
688
Nurses bear specific legal responsibilities under several federal statutes, including:
688
Standards of Care I
731
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
731


